Multicenter phase III trial of adjuvant chemoradiotherapy in stomach tumors 2 (ARTIST 2). Clinical activity of AMG 337, an oral MET kinase inhibitor, in adult patients (pts) with MET-amplified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback